McKesson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade McKesson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions (RxTS), and Medical-Surgical Solutions. 

CEO
Brian Scott Tyler
CEOBrian Scott Tyler
Employees
43,000
Employees43,000
Headquarters
Irving, Texas
HeadquartersIrving, Texas
Founded
1833
Founded1833
Employees
43,000
Employees43,000

MCK Key Statistics

Market cap
89.86B
Market cap89.86B
Price-Earnings ratio
19.73
Price-Earnings ratio19.73
Dividend yield
0.42%
Dividend yield0.42%
Average volume
1.48M
Average volume1.48M
High today
$761.98
High today$761.98
Low today
$742.10
Low today$742.10
Open price
$761.00
Open price$761.00
Volume
683.49K
Volume683.49K
52 Week high
$999.00
52 Week high$999.00
52 Week low
$637.00
52 Week low$637.00

Stock Snapshot

With a market cap of 89.86B, McKesson(MCK) trades at $747.58. The stock has a price-to-earnings ratio of 19.73 and currently yields dividends of 41.9%.

During the trading session on 2026-05-29, McKesson(MCK) shares reached a daily high of $761.98 and a low of $742.10. At a current price of $747.58, the stock is +0.7% higher than the low and still -1.9% under the high.

Trading activity shows a volume of 683.49K, compared to an average daily volume of 1.48M.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

The stock's 52-week range extends from a low of $637.00 to a high of $999.00.

MCK News

Simply Wall St 2d
Assessing McKesson Valuation After Recent Share Price Weakness And Cooling Long Term Momentum

McKesson (MCK) stock has drawn fresh attention after recent trading, with the share price around $754.40 and returns down over the past month and past 3 months....

Assessing McKesson Valuation After Recent Share Price Weakness And Cooling Long Term Momentum
Investing.com 2d
McKesson EVP and chief legal officer Michele Lau sells $2.7m in stock - Investing.com

...

McKesson EVP and chief legal officer Michele Lau sells $2.7m in stock - Investing.com
Simply Wall St 6d
McKesson Expands Oncology Data Reach As Investors Weigh Valuation Gap

Ontada, McKesson's oncology insights business, has entered a data partnership with Florida Cancer Specialists & Research Institute. The agreement integrates Fl...

McKesson Expands Oncology Data Reach As Investors Weigh Valuation Gap

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
9.5%
Sell
0%

People also own

Based on the portfolios of people who own MCK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.